Article
An implantable tibial nerve stimulation device appears to be safe and durable in patients with overactive bladder, results of a long-term pilot study showed.
Pivotal trial launches of 64Cu-SAR-bisPSMA in BCR of prostate cancer
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
Experts share insights on next-generation NMIBC therapies
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
Urologic surgeons successfully complete world’s first bladder transplant
Patient selection for cytoreductive nephrectomy in 2025
Meeting with FDA paves way for phase 3 trial of PT-112 in mCRPC
Study shows value of precision-based approaches in prostate cancer